Major limb amputation and mortality in patients with neuro‐ischaemic lower extremity wounds managed in a tertiary hospital: Focus on the differences among patients with diabetes, peripheral arterial disease and both

A majority of lower extremities neuro‐ischaemic wounds (NIU) are related to: (a) only diabetes (DM); (b) only peripheral artery disease (PAD); (c) co‐existing diabetes and peripheral artery disease (DM‐PAD). This study aims to characterise the major clinical outcomes of forementioned three groups of lower extremity wound patients in Singapore. Patients hospitalised for lower extremity NIU between January 2014 and October 2017 in a tertiary hospital in Singapore were analysed. Patients' major limb amputation and mortality were assessed using Cox regression models. Cumulative survival and amputation‐free survival among the three classified groups were calculated using Kaplan‐Meier analysis. Compared with patients with only DM, those in the PAD group and the DM‐PAD group had higher risk of major limb amputation (adjusted hazard ratio: 2.47, 95% CI: 1.65‐3.70; adjusted hazard ratio: 2.01, 95% CI: 1.53‐2.65 respectively) and mortality (adjusted hazard ratio: 2.36, 95% CI: 1.57‐3.55; adjusted hazard ratio: 2.46, 95% CI: 1.86‐3.26 respectively). The 3‐year survival and amputation‐free survival were lowest in the DM‐PAD group (52.1% and 41.5% respectively), followed by the PAD group (53.3% and 44.6% respectively) and the DM group (74.2% and 68.5% respectively). Lower extremity NIU patients with PAD or DM‐PAD were found to have poorer clinical prognosis than those with DM only.

[1]  J. García-Klepzig,et al.  Effectiveness of fast-track pathway for diabetic foot ulcerations , 2021, Acta Diabetologica.

[2]  R. Sayers,et al.  Does the Introduction of a Vascular Limb Salvage Service Improve One Year Amputation Outcomes for Patients with Chronic Limb-Threatening Ischaemia? , 2021, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  C. Assi,et al.  A meta-analysis of mortality following minor amputation among patients with diabetes and/or peripheral vascular disease. , 2020, Journal of vascular surgery.

[4]  C. Gazzaruso,et al.  Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a 10-year retrospective cohort study , 2020, Endocrine.

[5]  M. Creager,et al.  Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[6]  A. Farcomeni,et al.  Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis , 2020, Thrombosis and Haemostasis.

[7]  D. Armstrong,et al.  Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer , 2020, Journal of Foot and Ankle Research.

[8]  J. Car,et al.  Clinical and economic burden of wound care in the tropics: a 5‐year institutional population health review , 2020, International wound journal.

[9]  Benjamin A Lipsky,et al.  Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update) , 2020, Diabetes/metabolism research and reviews.

[10]  W. Jeffcoate,et al.  Diabetic foot ulcer classifications: A critical review , 2020, Diabetes/metabolism research and reviews.

[11]  T. Ferenci,et al.  Potentials, challenges, and limitations of the analysis of administrative data on vascular limb amputations in health care. , 2020, VASA. Zeitschrift fur Gefasskrankheiten.

[12]  S. Parikh,et al.  Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis , 2020, Vascular medicine.

[13]  I. Gezawa,et al.  Predictors of intra-hospital mortality in patients with diabetic foot ulcers in Nigeria: data from the MEDFUN study , 2019, BMC Endocrine Disorders.

[14]  S. Goldhaber,et al.  Peripheral Artery Disease: Past, Present, and Future. , 2019, The American journal of medicine.

[15]  N. Sattar,et al.  Population-based secular trends in lower-extremity amputation for diabetes and peripheral artery disease , 2019, Canadian Medical Association Journal.

[16]  M. Koelemay,et al.  The Prognostic Value of the WIfI Classification in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis. , 2019, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[17]  Josip Car,et al.  The humanistic and economic burden of chronic wounds: A systematic review , 2018, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[18]  A. Star Differentiating Lower Extremity Wounds: Arterial, Venous, Neurotrophic , 2018, Seminars in Interventional Radiology.

[19]  K. Hızel,et al.  Peripheral arterial disease increases the risk of multidrug-resistant bacteria and amputation in diabetic foot infections , 2018, Turkish journal of medical sciences.

[20]  Y. Khader,et al.  Predictors of major lower limb amputation in type 2 diabetic patients referred for hospital care with diabetic foot syndrome , 2018, Diabetes, metabolic syndrome and obesity : targets and therapy.

[21]  E. Wahlberg,et al.  Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome. , 2018, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[22]  V. Cervelli,et al.  Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers , 2018, Journal of clinical & translational endocrinology.

[23]  Nae-Ho Lee,et al.  Risk of major limb amputation in diabetic foot ulcer and accompanying disease: A meta-analysis. , 2017, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[24]  J. Black,et al.  The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification independently predicts wound healing in diabetic foot ulcers , 2017, Journal of vascular surgery.

[25]  E. Freisinger,et al.  Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis , 2017, Cardiovascular Diabetology.

[26]  L. Loretz,et al.  Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient‐centered outcomes in patients with threatened limbs managed in a limb preservation center , 2016, Journal of vascular surgery.

[27]  S. Chong,et al.  An economic evaluation of chronic wound management in a tertiary hospital , 2016 .

[28]  Holger Reinecke,et al.  Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome. , 2016, Journal of diabetes and its complications.

[29]  R. Kirsner,et al.  Lower‐extremity ulcers: diagnosis and management , 2015, The British journal of dermatology.

[30]  E. Armstrong,et al.  Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. , 2015, World journal of diabetes.

[31]  V. Aboyans,et al.  Epidemiology of peripheral artery disease. , 2015, Circulation research.

[32]  Amy T. Wang,et al.  A systematic review for the screening for peripheral arterial disease in asymptomatic patients. , 2015, Journal of vascular surgery.

[33]  G. Antoniou,et al.  Statin therapy in lower limb peripheral arterial disease: Systematic review and meta-analysis. , 2014, Vascular pharmacology.

[34]  C. Hu,et al.  Contribution of infection and peripheral artery disease to severity of diabetic foot ulcers in Chinese patients , 2014, International journal of clinical practice.

[35]  Lei Xu,et al.  Heart failure in hospitalized patients with diabetic foot ulcers: Clinical characteristics and their relationship with prognosis (糖尿病足溃疡住院患者的心衰:临床特点以及它们与预后的关系) , 2013, Journal of diabetes.

[36]  T. Wong,et al.  Distribution of ankle—brachial index and the risk factors of peripheral artery disease in a multi-ethnic Asian population , 2011, Vascular medicine.

[37]  L. Uccioli,et al.  Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study , 2008, Diabetologia.

[38]  L. Norgren,et al.  Inter-society consensus for the management of peripheral arterial disease. , 2007, International angiology : a journal of the International Union of Angiology.

[39]  É. Allaire,et al.  Foot Gangrene in Patients with End-Stage Renal Disease: A Case Control Study , 2006, Angiology.

[40]  A. Jirkovska,et al.  Comparison of microbial findings and resistance to antibiotics between transplant patients, patients on hemodialysis, and other patients with the diabetic foot. , 2004, Journal of diabetes and its complications.

[41]  M. Criqui,et al.  Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care , 2001 .

[42]  Marcia Nusgart,et al.  An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[43]  David G Armstrong,et al.  The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). , 2014, Journal of vascular surgery.

[44]  T. Dinh,et al.  Role of Peripheral Neuropathy in the Development of Foot Ulceration and Impaired Wound Healing in Diabetes Mellitus , 2012 .

[45]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.